These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8658611)

  • 1. Malignancy in organ transplantation recipients.
    Sheil AG
    Transplant Proc; 1996 Jun; 28(3):1162. PubMed ID: 8658611
    [No Abstract]   [Full Text] [Related]  

  • 2. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP; Patton PR; Meier-Kriesche HU; Li Q; Shenkman B; Fujita S; Reed A; Hemming AW; Kim RD; Howard RJ
    Clin Transpl; 2005; ():101-9. PubMed ID: 17424728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and surgical complications after kidney transplantation from "suboptimal donors": one centre's experience.
    Battaglia M; Ditonno P; Selvaggio O; Peschechera R; Ricapito V; DeCeglie G; Schena A; Stallone G; Schena FP; Falagario M; Selvaggi FP
    Transplant Proc; 2004 Apr; 36(3):493-4. PubMed ID: 15110568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy in renal recipients.
    Samhan M; Al-Mousawi M; Donia F; Fathi T; Nasim J; Nampoory MR
    Transplant Proc; 2005 Sep; 37(7):3068-70. PubMed ID: 16213307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human immunodeficiency virus and acquired immunodeficiency syndrome: a new problem in transplantation].
    Troshin AZ; Prianikov AE; Bronskaia LK
    Khirurgiia (Mosk); 1992; (9-10):87-90. PubMed ID: 1474799
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancy following kidney transplantation.
    Arichi N; Kishikawa H; Nishimura K; Mitsui Y; Namba Y; Tokugawa S; Ichikawa Y
    Transplant Proc; 2008 Sep; 40(7):2400-2. PubMed ID: 18790247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of donor diseases: efforts to protect recipients and increase deceased donor organ transplants.
    Morris P; Monaco A
    Transplantation; 2008 Apr; 85(8 Suppl):S49-50. PubMed ID: 18425035
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal transplantation in children.
    Samhan M; Fathi T; Al-Kandari N; Buresley S; Nampoory MR; Nair P; Halim M; Al-Mousawi M
    Transplant Proc; 2007 May; 39(4):911-3. PubMed ID: 17524848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
    Reddy KS; Stablein D; Taranto S; Stratta RJ; Johnston TD; Waid TH; McKeown JW; Lucas BA; Ranjan D
    Am J Kidney Dis; 2003 Feb; 41(2):464-70. PubMed ID: 12552511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Presentation of cancers in recipients of a solid-organ transplant].
    Lampreabe I; Gómez-Ullate P; Amenábar JJ; Zárraga S; Gaínza FJ; Urbizu JM
    Nefrologia; 2001; 21(6):528-37. PubMed ID: 11881422
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplant recipient's knowledge of posttransplant malignancy risk: implications for educational programs.
    Kauffman HM; Woodle ES; Cole EH; Paykin C;
    Transplantation; 2008 Apr; 85(7):928-33. PubMed ID: 18408569
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of malignancy following living donor kidney transplantation.
    Nafar M; Einollahi B; Hemati K; Gholi FP; Firouzan A
    Transplant Proc; 2005 Sep; 37(7):3065-7. PubMed ID: 16213306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of renal transplantation outcomes in children admitted to a paediatric intensive care unit in Brazil.
    Kusahara DM; Rocha PK; Peterlini MA; Pedreira ML; de Carvalho WB
    Nurs Crit Care; 2006; 11(6):281-7. PubMed ID: 17883676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal complications in patients with solid organ or bone marrow transplantations.
    Chung H; Kim KH; Kim JG; Lee SY; Yoon YH
    Transplantation; 2007 Mar; 83(6):694-9. PubMed ID: 17414700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged rehospitalizations following renal transplantation: causes, risk factors, and outcomes.
    Naderi M; Aslani J; Hashemi M; Assari S; Amini M; Pourfarziani V
    Transplant Proc; 2007 May; 39(4):978-80. PubMed ID: 17524867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update.
    Gjertson DW
    Clin Transpl; 1996; ():343-60. PubMed ID: 9286581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.